🚀 ProPicks AI Hits +34.9% Return!Read Now

Versum urges shareholders to reject Merck KGaA hostile bid

Published 29/03/2019, 12:55
© Reuters. FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt
APD
-

(Reuters) - Versum Materials Inc on Friday urged its shareholders to reject a hostile bid from Merck KGaA, but said it would engage with the German pharma group to determine if the offer is superior to its agreed merger with rival Entegris.

Merck KGaA had on Tuesday launched a $5.9 billion all-cash takeover offer for Versum, the former speciality chemicals division of industrial gases group Air Products (NYSE:APD), to boost its presence in the semiconductor materials market and sideline a rival bidder.

Versum has been opposed to Merck's bid since it was first proposed last month, saying it was committed to an all-share merger with U.S. rival Entegris agreed in January.

Versum said on Friday it has been granted a waiver by Entegris that allows it to engage with, but not provide non-public information to Merck.

Merck could improve terms of the offer, Versum said, adding that it has not changed its recommendation to back its merger with Entegris.

© Reuters. FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt

The move is also the first major hostile takeover bid by a German company for a U.S. target since BASF's 2006 approach for catalytic converter maker Engelhard, which ended up becoming an agreed deal.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.